O'Dwyer, M E <br/><br/>
The role of the tyrosine kinase inhibitor STI571 in the treatment of cancer.  [electronic resource] 

 -  Current cancer drug targets  May 2001 
 - 49-57 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1568-0096 
<br/><br/><label>Standard No.: </label>10.2174/1568009013334250  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Benzamides<br/>Clinical Trials as Topic<br/>Drug Design<br/>Drug Evaluation<br/>Enzyme Inhibitors--therapeutic use<br/>Fusion Proteins, bcr-abl--antagonists & inhibitors<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Piperazines--therapeutic use<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrimidines--therapeutic use